- Home
- DTCX vs FBIO Comparison
DTCX vs FBIO Comparison
Compare DTCX & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$2.18
HOLD
Current Price
$2.76
Company Overview
Basic Information| Metric | DTCX | FBIO |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | N/A | 78 |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 77.1M | 91.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | DTCX | FBIO |
|---|---|---|
| Price | $2.18 | $2.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 245.1K | ★ 342.8K |
| Earning Date | 04-13-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $55.22 |
| Revenue Next Year | N/A | $40.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.51 | $1.75 |
| 52 Week High | $3.80 | $4.53 |
Technical Indicators
Market Signals| Indicator | DTCX | FBIO |
|---|---|---|
| Relative Strength Index (RSI) | 45.24 | 63.51 |
| Support Level | $1.82 | $2.42 |
| Resistance Level | $2.34 | $2.83 |
| Average True Range (ATR) | 0.13 | 0.14 |
| MACD | -0.01 | 0.07 |
| Stochastic Oscillator | 21.05 | 83.09 |
Price Performance
Historical Comparison DTCX
FBIO
About DTCX Datacentrex Inc. Common Stock
Datacentrex Inc maintains a digital asset treasury composed of assets generated through its mining hashrate, including Dogecoin (DOGE), Litecoin (LTC), and Bitcoin (BTC).
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.